Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease (CKD) Sub-study to Protocol Number 1308084213
Status: Enrolling
Updated:  12/31/1969
University Hospital
mi
from
Indianapolis, IN
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease (CKD) Sub-study to Protocol Number 1308084213
Status: Enrolling
Updated: 12/31/1969
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Healthcare System
mi
from
Salt Lake City, UT
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Healthcare System
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Mobile, AL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Peoria, AZ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Peoria, AZ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Tempe, AZ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Los Angeles, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Palo Alto, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
San Diego, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site 2
mi
from
Aurora, CO
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site 2
mi
from
Aurora, CO
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
New Haven, CT
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Jacksonville, FL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Port Charlotte, FL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Atlanta, GA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Augusta, GA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Chicago, IL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Kansas City, KA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Baton Rouge, LA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Baltimore, MD
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Rockville, MD
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Boston, MA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Detroit, MI
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Minneapolis, MN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Rochester, MN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Voorhees, NJ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Buffalo, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Hawthorne, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
New York, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Chapel Hill, NC
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Cincinnati, OH
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Cleveland, OH
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Portland, OR
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Philadelphia, PA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Anderson, SC
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Nashville, TN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Arlington, TX
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Arlington, TX
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
McAllen, TX
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
McAllen, TX
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Charlottesville, VA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
C.a.b.a.,
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
C.a.b.a.,
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
mi
from
Bethlehem, PA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Necker Hospital
mi
from
Paris,
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Necker Hospital
mi
from
Paris,
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
Fresenius Medical Services
mi
from
Waltham, MA
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
Fresenius Medical Services
mi
from
Waltham, MA
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
mi
from
Minneapolis, MN
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
Salford Royal Hospital
mi
from
Salford,
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
Salford Royal Hospital
mi
from
Salford,
Click here to add this to my saved trials
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated:  12/31/1969
UNC Ophthalmology
mi
from
Chapel Hill, NC
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated: 12/31/1969
UNC Ophthalmology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Minneapolis, MN
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Miami, FL
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials